Literature DB >> 28261593

Staging of intrahepatic cholangiocarcinoma.

Sean M Ronnekleiv-Kelly1, Timothy M Pawlik2.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) comprises approximately 5-30% of primary liver tumors, however it has been increasing over the last several decades. Up to and including the 6th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) edition staging system, ICC was staged the same as hepatocellular carcinoma. In the 7th edition AJCC/UICC manual, the staging system of ICC was revised such that a distinct classification was proposed. Pathologic features for prognosis included vascular invasion, tumor multiplicity, local extension, periductal infiltration and lymph nodal metastasis. Over the last decade, as the incidence of ICC has increased and surgery for this indication has become more common, more data has been published on the prognostic factors associated with long-term survival.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma (ICC); prognostic factors; staging

Year:  2017        PMID: 28261593      PMCID: PMC5332207          DOI: 10.21037/hbsn.2016.10.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  38 in total

1.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

Review 2.  Staging of intrahepatic cholangiocarcinoma.

Authors:  Hari Nathan; Timothy M Pawlik
Journal:  Curr Opin Gastroenterol       Date:  2010-05       Impact factor: 3.287

3.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Authors:  Sae-Byeol Choi; Kyung-Sik Kim; Jin-Young Choi; Seung-Woo Park; Jin-Sub Choi; Woo-Jung Lee; Jae-Bock Chung
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

4.  A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.

Authors:  T Okabayashi; J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

5.  Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications.

Authors:  Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Yu Takahashi; Masato Nagino
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

6.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

Review 7.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

8.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

9.  Hepatobiliary cancers, version 2.2014.

Authors:  Al B Benson; Michael I D'Angelica; Thomas A Abrams; Chandrakanth Are; P Mark Bloomston; Daniel T Chang; Bryan M Clary; Anne M Covey; William D Ensminger; Renuka Iyer; R Kate Kelley; David Linehan; Mokenge P Malafa; Steven G Meranze; James O Park; Timothy Pawlik; James A Posey; Courtney Scaife; Tracey Schefter; Elin R Sigurdson; G Gary Tian; Jean-Nicolas Vauthey; Alan P Venook; Yun Yen; Andrew X Zhu; Karin G Hoffmann; Nicole R McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-08       Impact factor: 11.908

10.  Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients.

Authors:  Dario Ribero; Antonio Daniele Pinna; Alfredo Guglielmi; Antonio Ponti; Gennaro Nuzzo; Stefano Maria Giulini; Luca Aldrighetti; Fulvio Calise; Giorgio Enrico Gerunda; Mariano Tomatis; Marco Amisano; Pasquale Berloco; Guido Torzilli; Lorenzo Capussotti
Journal:  Arch Surg       Date:  2012-12
View more
  15 in total

1.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

2.  The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Katiuscha Merath; Malcolm H Squires; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-01-19       Impact factor: 3.452

3.  Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.

Authors:  Xu-Feng Zhang; Fabio Bagante; Jeffery Chakedis; Dimitrios Moris; Eliza W Beal; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

4.  Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.

Authors:  Ekapot Singsuksawat; Chanitra Thuwajit; Komgrid Charngkaew; Peti Thuwajit
Journal:  Cancer Cell Int       Date:  2018-02-20       Impact factor: 5.722

5.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

6.  Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation.

Authors:  Nattawan Suwannakul; Ning Ma; Raynoo Thanan; Somchai Pinlaor; Piti Ungarreevittaya; Kaoru Midorikawa; Yusuke Hiraku; Shinji Oikawa; Shosuke Kawanishi; Mariko Murata
Journal:  Mediators Inflamm       Date:  2018-10-09       Impact factor: 4.711

7.  Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.

Authors:  Angela Lamarca; Alvaro Santos-Laso; Kirsten Utpatel; Adelaida La Casta; Simone Stock; Alejandro Forner; Jorge Adeva; Trine Folseraas; Luca Fabris; Rocio I R Macias; Marcin Krawczyk; Marek Krawczyk; Vincenzo Cardinale; Chiara Braconi; Domenico Alvaro; Matthias Evert; Jesus M Banales; Juan W Valle
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.425

8.  Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy?

Authors:  Chen Jin; Xiao-Yun Zhang; Jia-Wu Li; Chuan Li; Wei Peng; Tian-Fu Wen; Yan Luo; Qiang Lu; Xiao-Fei Zhong; Jing-Yi Zhang; Lv-Nan Yan; Jia-Yin Yang
Journal:  Oncotarget       Date:  2017-07-27

9.  A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma.

Authors:  Bo-Hao Zheng; Liu-Xiao Yang; Qi-Man Sun; Hong-Kai Fan; Men Duan; Jie-Yi Shi; Xiao-Ying Wang; Jian Zhou; Jia Fan; Zheng-Yao Ma; Qiang Gao
Journal:  Clin Transl Gastroenterol       Date:  2017-10-05       Impact factor: 4.488

10.  Multiplicity of Advanced T Category-Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma.

Authors:  Hye Eun Park; Seungyeon Yoo; Jeong Mo Bae; Seorin Jeong; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  J Pathol Transl Med       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.